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Abstract
The genetic basis underlying liver fibrosis remains largely unknown. We conducted a study to 
identify genetic alleles and underlying pathways associated with hepatic fibrogenesis and fibrosis 
at the genome-wide level in 121 human livers. By accepting a liberal significance level of P<1e-4, 
we identified 73 and 71 candidate loci respectively affecting the variability in alpha-smooth 
muscle actin (α-SMA) levels (fibrogenesis) and total collagen content (fibrosis). The top genetic 
loci associated with the two markers were BAZA1 and NOL10 for α-SMA expression and 
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FAM46A for total collagen content (P<1e-6). We further investigated the relationship between the 
candidate loci and the nearby gene transcription levels (cis-expression quantitative trait loci) in the 
same liver samples. We found that 44 candidate loci for α-SMA expression and 44 for total 
collagen content were also associated with the transcription of the nearby genes (P<0.05). Pathway 
analyses of these genes indicated that macrophage migration inhibitory factor (MIF) related 
pathway is significantly associated with fibrogenesis and fibrosis, though different genes were 
enriched for each marker. The association between the single nucleotide polymorphisms, MIF and 
α-SMA showed that decreased MIF expression is correlated with increased α-SMA expression, 
suggesting that variations in MIF locus might affect the susceptibility of fibrogenesis through 
controlling MIF gene expression. In summary, our study identified candidate alleles and pathways 
underlying both fibrogenesis and fibrosis in human livers. Our bioinformatics analyses suggested 
MIF pathway as a strong candidate involved in liver fibrosis, thus further investigation for the role 
of the MIF pathway in liver fibrosis is warranted. The study was reviewed and approved by the 
Institutional Review Board (IRB) of Wayne State University (approval No. 201842) on May 17, 
2018.
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Introduction
Hepatic fibrosis is a highly conserved and protective response characterized by the excessive 
accumulation of extracellular matrix proteins following either acute or chronic liver injury.[1] 
Chronic viral hepatitis, alcohol abuse, and non-alcoholic fatty liver disease are the main 
causes of liver fibrosis.[2] Although normal liver composition can be restored following 
acute or transient insult, sustained chronic liver injury will lead to a progressive formation of 
fibrous scar tissue, which will destroy the liver architecture and eventually produce 
hepatocellular dysfunction.[3] The pathogenesis of liver fibrosis is not fully understood, and 
it remains largely unclear why the severity of the disease displays substantial variability in 
patients with the same set of known risk factors.[4] Therefore, there is a pressing need to 
understand the genetic basis underlying the liver fibrosis which may subsequently allow for 
identifying critical drug targets can be identified and early intervention strategies for 
subjects with high risk of liver disease can be developed.
The expression of alpha-smooth muscle actin (α-SMA) reflects the activation of hepatic 
stellate cells to myofibroblast-like cells and is closely related to human liver fibrogenesis.[5] 
Sirius red staining can accurately quantify the total hepatic collagen content,[6] which is 
among the predominant hepatic extracellular matrix proteins.[7] Therefore, quantitative α-
SMA expression and Sirius red staining are accurate and reliable markers indicating liver 
fibrogenesis and fibrosis, respectively. In this study, we explored the genetic basis 
underlying the variability of these two quantitative molecular phenotypes using a step-wise 
genome-wide analysis, using donor liver samples which reflects a general American 
population. We performed genome-wide association study on the quantitative level of the 
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two markers. We further investigated the potential function of candidate single nucleotide 
polymorphisms (SNPs) in regulating mRNA expression for their nearby genes. A pathway 
enrichment analysis was further conducted to identify critical genes and pathways that are 
potentially underlying the genetic susceptibility to liver fibrosis.
Materials and methods
Datasets
The tissue procurement procedure and related information of the liver samples (n=121) used 
in this cross-sectional study have been described in our previous studies.[8–10] In brief, these 
liver samples were obtained from unrelated liver transplantation donors of self-reported 
European and African descent. Subjects with heavy alcohol consumption (>20g/day), 
hepatitis B and C virus infection, or drug-induced liver injury, were excluded from this 
study. The genotype and gene expression profiling of these samples have been previously 
analyzed and deposited to the Gene Expression Omnibus database (accession number: 
GSE26106, https://www.ncbi.nlm.nih.gov/geo/). The demographical and histological 
characteristics of the donor liver samples used in this study have been summarized in Table 
1. Analyses in this study were performed on anonymous individuals, thus this study is not 
considered to involve “human subjects”. The study was reviewed and has been approved by 
the Institutional Review Board (IRB) of Wayne State University (approval No. 201842) on 
May 17, 2018.
Liver histology characterization and α-SMA and sirius red staining and quantification
Formalin-fixed, paraffin-embedded liver sections were stained with hematoxylin and eosin 
and Masson trichrome stains for histological evaluation. The biopsies were scored by an 
experienced hepatopathologist (JL) in a blinded fashion according to the non-alcoholic 
steatohepatitis clinical research network liver histology criteria published by Kleiner et al[11] 
and it showed normal in 59% and non-alcoholic fatty liver disease in 41% [fatty liver 5%, 
borderline non-alcoholic steatohepatitis 23%, and definite non-alcoholic steatohepatitis in 
13%. Formalin-fixed, paraffin-embedded sections were stained for α-SMA (marker for 
stellate cell activation) and Sirius red (total collagen content) and were digitally quantitated 
and expressed as a percent of total liver biopsy area using SPSS Sigma Scan Pro 5.0 
software (SPSS Inc., Chicago, IL, USA).
Genome-wide association study (GWAS) analyses
Genotyping was performed using Illumina Human610-Quad v1.0 BeadChip array (Illumina, 
San Diego, CA, USA).[8] The overall genotyping rate was 95.16%. After excluding rare 
(minor allele frequencies <5%) and low quality (call rate <90% and deviation from Hardy-
Weinberg equilibrium P < 1e-3) variants, there are 533,687 remaining SNPs for the linear 
regression analysis. Using an additive genetic model, each SNP was tested for association to 
α-SMA expression and hepatic collagen content, respectively. The phenotypes were 
normalized with log base 10 transformation. Age, gender, body mass index, and the first two 
genetic principal components were adjusted as covariates for the association. SNPs with P 
value less than 1e-4 were considered as candidate loci for the following analysis. The quality 
control and association test was performed using the package PLINK 1.07 (http://
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pngu.mgh.harvard.edu/purcell/plink/).[12] The regional plots were generated using the 
package LocusZoom (http://csg.sph.umich.edu/locuszoom/).[13]
Expression quantitative trait loci (eQTL) analyses
Gene expression profiling was measured using Agilent-014850 Whole Human Genome 
Microarray 4×44K (Agilent, Santa Clara, CA, USA) for the liver tissues of the same set of 
subjects.[8] Linear regression model was used to detect transcripts significantly associated 
with the lead GWAS loci within ±1Mbp region. Age, gender, body mass index, and the first 
two genetic principal components were used as covariates. Associations with P value less 
than 0.05 were considered as significant for the following analysis. The eQTL analyses were 
performed using R package Matrix eQTL.[14]
Pathway enrichment analyses
We used QIAGEN’s Ingenuity® Pathway Analysis (IPA®, QIAGEN Redwood City, CA, 
USA; www.qiagen.com/ingenuity) to identify overrepresented signaling pathways in eQTL-
controlling genes. Right-tailed Fisher’s exact test was used to determine the significance 
level of signaling pathways, and P<0.05 was considered significant.
Gene interactions from curated databases and text-mining
The Gene Interactions tool in University of California, Santa Cruz Genome Browser (https://
genome.ucsc.edu) was used to search the gene-gene interactions. Two genes were 
considered to be interacted if the interaction has been supported by either curated databases 
or text-mining. The curated databases consist of 23 pathway or protein interactions 
databases. A full list of databases that have been included can be found in the user guide of 
Gene Interactions tool (https://genome.ucsc.edu/goldenPath/help/hgGeneGraph.html). The 
text-mining supported gene interactions were generated by the Literome machine-reading 
program, which read and extracted the gene interactions from 20 million PubMed abstracts 
by the end of 2014.[15] The gene–gene interactions among a given list of genes were 
visualized through igraph 1.0.0 (http://igraph.org).
Statistical analysis
Linear regression was used to assess the association between genetic variants and fibrosis 
markers or gene expression levels. Age, gender, body mass index, and the first 2 genetic 
principal components were used as covariates in the linear regression model. For GWAS 
analysis, P value less than 1e-4 were considered as candidate loci for the following analysis. 
As for the eQTL analysis, P value less than 0.05 were considered as significant for the 
following analysis. The demographical and histological features of the samples were 
expressed as number (percentage) for categorical variables and median (interquartile range) 
for continuous variables. The correlations between MIF gene expression and α-SMA 
expression and total collagen content were evaluated by Pearson correlation test, and P<0.05 
was considered statistically significant. The statistical tests were performed using R 3.4 
(https://www.r-project.org).
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GWAS analysis identifies multiple loci affecting α-SMA expression and total collagen 
content
The workflow of the study is shown in Figure 1. The two phenotypes explored by GWAS are 
positively correlated with each other (r=0.31, P=6.6e-4). After GWAS, no SNP was 
identified with a typical genome-wide significance (5e-8) in correlation with each 
phenotype. At a suggestive level of P<1e-4, there were 73 and 71 candidate genetic variants 
associated with α-SMA expression and total collagen content, respectively. Although there 
is a moderate correlation between the two markers, only 3 SNPs (rs1274369, rs1274351, 
rs1274323) were commonly associated with both markers. The Manhattan plots and Q–Q 
plots of the GWAS are shown in Figure 2, and the characteristics of the top 10 association 
loci are summarized in Table 2.
Top GWAS hits for α-SMA expression includes an intronic SNP rs8015303 in BAZ1A 
(bromodomain adjacent to zinc finger domain 1A) which encodes a protein subunit of the 
ATP-dependent chromatin assembly factor that involved in chromatin remodeling. An 
intronic SNP rs1012580 in the NOL10 (nucleolar protein 10) was also significantly 
associated with α-SMA expression. A few other top hits indicated that several genes 
involved in inflammation and immune response especially IL2RA (interleukin 2 receptor 
subunit alpha), HTR7 (5-hydroxytryptamine receptor 7), ST6GALNAC3 (ST6 N-acetyl-
galactosaminide alpha-2,6-sialyltransferase 3) and AOAH (acyloxyacyl hydrolase).
Top GWAS hits for total hepatic collagen content are mainly genes that are significantly 
related to cell skeleton structure, extracellular matrix and cell adhesion. These include 
ZWINT (ZW10 Interacting kinetochore protein) (spindle assembly),[16] BCAR3 (breast 
cancer anti-estrogen resistance 3) (cytoskeletal remodeling and adhesion),[17] EFNA5 
(ephrin-A5) (cell adhesion and morphology)[18] and COL11A2 (collagen type XI alpha 2 
chain).
Expression analysis identifies significant eQTLs for lead variants
The eQTL analysis can help establish the potential causality for the GWAS findings. To 
further explore the effects of GWAS loci on gene expression, we performed cis-eQTL 
analyses in the same set of liver tissues as the GWAS, by focusing on genes that are within 
the distance of ±1Mbp to GWAS identified candidate loci (P<1e-4). By accepting a liberal 
significance level of P=0.05 for eQTLs, we identified 102 significant eQTLs for 44 α-SMA-
associated variants and 77 eQTLs for 44 candidate GWAS loci associated with collagen 
content. The information of the full list of eQTLs is provided in Additional Table 1, http://
links.lww.com/JR9/A4.
Our results show that several variants are associated with the mRNA expression of their 
nearest genes. For example, rs1012580 in nucleolar protein 10 (NOL10) for α-SMA 
expression and rs13092046 in contactin 3 (CNTN3) for total collagen content are found to 
be correlated with the mRNA expression levels of their most nearby genes. However, other 
significant eQTLs may exert their effects on gene expression in a relatively broad range. For 
instance, fibrogenesis candidate variant rs12207 at TUBB3 locus is associated with the 
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expression levels of several nearby genes including charged multivesicular body protein 1A 
(CHMP1A), Fanconi anemia complementation group A (FANCA), VPS9 domain containing 
1 (VPS9D1), and paraplegin matrix AAA peptidase subunit (SPG7) instead of TUBB3 itself.
Top eQTLs for α-SMA expression include several variants in 22q11.23 locus that are 
significantly associated with the transcription levels of macrophage migration inhibitory 
factor (MIF) and glutathione S-transferase theta 2 (GSTT2) (Additional Table 1, http://
links.lww.com/JR9/A4). Top eQTL-controlling genes for total collagen content include two 
glycosyltransferases encoding genes, namely solute carrier family 35 member B4 
(SLC35B4) and beta-1,3-galactosyltransferase 4 (B3GALT4). The transcription of 
prostaglandin-endoperoxide synthase 2 (PTGS2), which encodes a cyclooxygenase involved 
in the MIF-related apoptosis repression, is significantly associated with collagen-related 
variants in 1q31.1 locus.
Pathway enrichment analysis of the eQTL-controlling genes
Given the polygenic nature of liver fibrosis, a single genetic variant or gene may only 
possess limited effect on the development and progression of the disease. We aim to identify 
pathways underlying the liver fibrosis that individual SNP-based GWAS analysis might 
miss. We conducted enrichment analyses on the candidate eQTL-controlling genes using the 
ingenuity pathway analysis package. In order to avoid missing key pathways, we assumed 
that those genes whose transcriptions are associated with the candidate SNPs at a nominal 
P<0.05 level are the candidate genes for an enrichment analysis. As shown in Table 3, 
eumelanin biosynthesis, ataxia telangiectasia mutated signaling, glutathione redox reactions 
I, vascular endothelial growth factor signaling, glutathione-mediated detoxification, MIF-
mediated glucocorticoid regulation, and MIF regulation of innate immunity pathways are top 
enriched pathways for the α-SMA activation. On the other hand, MIF-mediated 
glucocorticoid regulation, MIF regulation of innate immunity, branched-chain α-keto acid 
dehydrogenase complex, and glutathione ascorbate recycling pathways are enriched in 
candidate genes for total collage content.
Interestingly, although there is only a minimal overlap between the candidate genes 
associated with the 2 phenotypes, the MIF related pathways, as well as glutathione-S-
transferases (GSTs), are significantly enriched for both markers. A detailed inspection of the 
MIF gene SNPs identifies several variants near the MIF locus to be negatively associated 
with α-SMA levels (β= −0.43; 95%CI: −0.64, −0.23; P=8.38e-5) (Fig. 3B), but positively 
associated with MIF gene expression (β = 0.37; 95%CI: 0.30, 0.44; P=6.34e-7) (Fig. 3C). 
We found that MIF gene expression is significantly correlated with decreased levels of α-
SMA (Fig. 4A, r=−0.21, P=0.026), suggesting that variations in MIF locus might affect the 
susceptibility of fibrogenesis through controlling MIF gene expression. There is no 
significant correlation between MIF gene expression and total collagen content (Fig. 4B, 
P=0.29).
To further confirm this pathway enrichment, and to explore the possible mechanisms 
through which eQTL-controlling genes are involved in the development of fibrosis, we 
searched for the gene-gene interactions among candidate genes for α-SMA expression and 
total collagen content based on a text-mining based gene interaction database. Two genes 
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were considered to be interacted as long as this relationship has been supported by either 
curated gene interactions databases or text-mining evidence. As shown in Figure 5A, nitric 
oxide synthase 3 (NOS3) and MIF are the 2 genes that have the largest number of 
connections with other α-SMA expression-related genes. PTGS2, which mediates the MIF 
induced apoptosis suppression, is one of the most highly connected genes for the total 
collagen content-related gene network (Fig. 5B).
Discussion
Hepatic collagens accumulation and α-SMA activation are reliable and quantitative markers 
indicating the risk of developing liver fibrosis and cirrhosis,[19,20] thus are important 
intermediate phenotypes for the disease. Interrogating the genetic susceptibility loci for 
these intermediate phenotypes will gain insight into the molecular mechanisms involved in 
the pathogenesis of hepatic fibrosis and provide potential targets for early diagnosis and 
treatment. Our study for the first time identifies candidate genetic variants, genes, and 
pathways contributing to human liver fibrogenesis and fibrosis in a general population.
GWAS have been widely used to investigate the genetic basis of human complex diseases, 
and thousands of susceptibility loci have been identified thus far.[21] However, to date, most 
GWAS identified alleles only account for a modest proportion of total variance in traits. This 
is mainly because of the polygenic nature of complex traits and at least in part due to the 
multiple testing burden in test statistics.[22] A growing body of knowledge acknowledges 
that there are causal variants remain undetected owe to the adoption of stringent genome-
wide significance threshold level (P<5e-8).[23,24] Therefore, we set a relatively moderate 
threshold at P<1e-4 for GWAS to systematically evaluate the overall effects of candidate 
genetic variants on the two phenotypes. In addition, incorporating the information of eQTLs 
and evaluating them in a network way is beneficial to interpret the biological mechanisms 
underlying the discovered loci, thus potentially identifying causal alleles underlying the 
genetic association. As such, although our study did not identify any SNP that reaches the 
typical GWAS significance level, which could be largely attributed to the small sample size, 
our combined analyses indeed narrowed down a few interesting genes and pathways that are 
broadly supported by many previous studies.
Our analyses firstly demonstrated that a few genes involved in inflammation and immune 
response as top GWAS hits for α-SMA activation. This is consistent with the known 
relationship between α-SMA expression and hepatic stellate cell activation as a key step for 
liver fibrogenesis. One notable loci is IL2RA (CD25) across which multiple SNPs were 
previously associated with various inflammatory disorders and traits including allergy,[25] 
Epstein-Barr virus nuclear antigen-1 (EBNA-1) IgG level,[26] diisocyanate-induced asthma,
[27] inflammatory bowel disease,[28] autoimmune diseases,[29,30] rheumatoid arthritis,[31] 
multiple sclerosis,[32,33] and levels of autoantibodies in type 1 diabetes.[34] The top hit 
rs12722561 identified in our study is in complete linkage disequilibrium with rs12722489, a 
polymorphism previously identified in genome-wide meta-analyses as a susceptibility locus 
to multiple sclerosis[32] and Crohn disease.[35] A recent study has shown that variant in 
IL2RA was also significantly associated with the concentration of circulating IL2RA.[36] 
Importantly, the IL-2 signaling pathway was also enriched as one of the top pathways 
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associated with advanced fibrosis and cirrhosis in a genome-wide pathway analysis for non-
alcoholic fatty liver disease.[37] Mechanistically, the IL-2/IL2RA signaling has been 
indicated to be involved in the liver fibrosis as well. The stellate cell-lymphocyte interaction 
in the liver plays a pivotal role in stellate cell activation and liver fibrogenesis, and the 
IL2RA (CD25) and CD4 positive regulatory T cells (CD4+/CD25+) have been demonstrated 
to be anti-fibrotic by suppression the pro-fibrotic effect of CD8 cells on stellate cells.[38]
It is also not surprising that top GWAS hits for total collagen content are associated with 
multiple genes involved in cytoskeletal structure, extracellular matrix, cell migration and 
adhesion. In addition, two highly linked intronic SNPs at the COL11A2 (collagen type XI 
alpha 2 chain) locus are strongly associated with the total collagen content as well. 
Interestingly, these 2 SNPs are also significantly associated with mRNA expression of 
multiple genes within a ~250kb region in our liver tissue set including COL11A2 and 
multiple HLA genes. We further searched the genotype-tissue expression portal for these 
two SNPs, which turns out that they are also strong eQTLs for the similar set of the genes 
within the region among multiple tissues. Notably, this HLA locus has been previously 
linked with hepatitis B virus/hepatitis C virus-related liver cirrhosis[39,40] as well as primary 
biliary cirrhosis,[41] suggesting an essential role of these genes in increasing the 
susceptibility to liver fibrosis.
It is known that the typical GWAS approach may miss important genetic loci as only the 
very top significant SNPs are selected. We therefore further performed a pathway 
enrichment analysis by focusing on the genes whose mRNA expression is likely to be 
affected by the candidate SNPs that are associated with the two markers using a liberal cut-
off of P<1e-4. Interestingly, the glutathione-related genes and MIF-related pathways are the 
two common major pathways enriched for both markers. It should be noted that there is only 
a minimal overlap between the candidate genes associated with each of the 2 markers, 
suggesting that despite different genes, the underlying pathways still stand out. While it is 
known that GSTs are protective for oxidative stress-mediated liver damage.[42] MIF related 
signaling pathway has been strongly linked to liver fibrosis as well. A recent study 
demonstrated that MIF-deleted mice (Mif−/−) tend to show exaggerated fibrogenic 
phenotypes in 2 chronic liver injury models.[43] This study is consistent with our finding that 
MIF may exert anti-fibrotic effects in human livers. Moreover, other eQTL-controlling genes 
in MIF pathway, including PLA2 and PTGS2, are key mediators of MIF induced apoptosis 
suppression signaling, indicating apoptosis repression might be one of the mechanisms for 
the antifibrotic effects of MIF.[44]
In addition, angiogenesis has been significantly involved in liver fibrosis.[45,46] Indeed, our 
pathway enrichment analysis identified that NOS3 and vascular endothelial growth factor 
signaling pathways are significantly associated with α-SMA expression, while the 
endothelin-1 signaling pathway is significantly pathway is associated with total collagen 
level. A considerable body of evidence demonstrates that vascular endothelial growth factor 
signaling promotes liver fibrogenesis by stimulating activated stellate cells growth, 
migration, and collagen production.[47,48] It has been also shown that NOS3 expression and 
activation plays a critical role in the development of FLD and liver fibrosis.[49–51]
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We further explore the potential interaction network between the key genes and pathways. 
Again, the NOS3 and MIF are the most highly connected genes for the α-SMA expression 
gene network. Our results suggested that the 2 hub genes, NOS3 and MIF, and their related 
genes were connected through MutS homolog 4 (MSH4), suggesting that the crosstalk 
between NOS3 and MIF signaling pathways might be critical for the liver fibrogenesis. 
However, this hypothesis needs to be validated through further investigations. As for the 
gene interaction network of the total collagen content related genes, PTGS2 has the largest 
number of connections. Again, it is notable that PTGS2 is also involved in both the MIF and 
endothelin-1 signaling pathway, which may further indicate that the MIF and angiogenesis 
signaling are both involved in liver fibrosis. It should be noted again that the interaction 
networks for both phenotypes highlighted the MIF signaling pathway although there is 
limited overlap between eQTL-controlling genes for the two phenotypes. Therefore, the role 
of MIF signaling, especially its potential interaction with the angiogenesis pathway needs to 
be further investigated.
There are also several limitations of our study. Due to the moderate sample size, our 
analyses are limited in its power for identifying genetic risk loci. In addition, we adopted a 
generous threshold to incorporate more potential causal variants into analysis. This will 
inevitably increase the false positive rate of our test. Therefore, the susceptibility loci 
identified in our study should be considered as suggestive and need to be validated 
independently and within more diverse cohorts.
In conclusion, our study identified candidate genetic variants and pathways significantly 
associated with intermediate markers for liver fibrogenesis and fibrosis. Our findings would 
be helpful to elucidate the genetic basis underlying the inter-individual differences in the 
development of liver fibrosis and provide candidate targets for developing therapeutic 
strategies.
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Flowchart showing the workflow of the analysis. White boxes represent the input data of 
human liver samples. Grey boxes indicate the significant output of analysis. α-SMA=alpha-
smooth muscle actin, eQTL=expression quantitative trait loci, GST=glutathione S-
transferase, MIF=macrophage migration inhibitory factor, SNP=single nucleotide 
polymorphism.
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Genome-wide association studies of α-SMA expression and total collagen content. (A, B) 
Manhattan plot and quantile-quantile plot for GWAS of α-SMA expression. (C, D) 
Manhattan plot and quantile-quantile plot for GWAS of total collagen content. P values were 
calculated by using multiple linear regression model adjusted for age, gender, body mass 
index, and first two principle components. The horizontal red lines indicate the suggestive 
significance threshold (P<1e-4) used for further analysis. α-SMA=alpha-smooth muscle 
actin, GWAS=genome-wide association study.
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Association between variants near MIF locus and MIF gene expression and α-SMA levels. 
(A) Regional plot for MIF locus. Each SNP is plotted with its P value (shown as −log10 (P 
value)) as a function of its genomic coordinate (Hg 18). The local LD structure was 
estimated based on 1000 Genomes 2010 CEU; B: Negative association between MIF 
rs5996635 and α-SMA expression levels (β = −0.43; 95%CI: −0.64, −0.23; P = 8.38e-5). P 
values were calculated by using multiple linear regression model adjusted for age, gender, 
BMI, and first 2 principle components. (C) Positive association between MIF rs5996635 and 
MIF transcription (β = 0.37; 95%CI: 0.30, 0.44; P=6.34e-7). A multiple linear regression 
model was used to test the association between MIF expression levels and nearby GWAS 
loci within ±1Mbp region. Age, gender, body mass index, and the first two genetic principal 
components were used as covariates. Numbers of individuals with AA, AG, and GG 
genotypes are 88, 32, and 1, respectively. α-SMA=alpha-smooth muscle actin, GWAS 
=genome-wide association study, MIF=macrophage migration inhibitory factor, SNP=single 
nucleotide polymorphism.
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Correlation between MIF gene expression and α-SMA expression and total collagen 
content. (A) Negative correlation (r=−0.21, P=0.026) between MIF gene expression and α-
SMA expression. (B) Correlation (r=−0.10, P=0.29) between MIF gene expression and total 
collagen content. P values were calculated by Pearson correlation test. α-SMA=alpha-
smooth muscle actin, MIF=macrophage migration inhibitory factor.
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Gene interaction networks for eQTL-controlling genes. (A) Gene interactions for α-SMA 
expression-related genes. (B) Gene interactions for total collagen content-related genes. The 
grayscale intensity of the node represents the number of its edges. The darker the node is, 
the more connections it has. α-SMA=alpha-smooth muscle actin, eQTL=expression 
quantitative trait loci.
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Table 1
Demographical and histological characteristics of the donor liver tissues.
Item Data
Male 82 (67.8)
Age (year) 40 (17–57)
body mass index (kg/m2) 25.8 (21.8–29.8)
Race
 White 102 (84.3)
 Black 19 (15.7)
Percentage of alpha-smooth muscle actin expression 3.6 (1.8–7.1)
Percentage of total collagen content 9.4 (5.5–14.1)
Fibrosis stage*
 Focal perisinusoidal 1(0.9)
 Perisinusoidal 6 (5.2)
 No fibrosis 109 (93.9)
N = 121.
*
missing information for 5 participants. Data are expressed as number (percent) in male, race, and fibrosis stage, and median (interquartile range) 
in others.
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